Literature DB >> 9067630

Different sensitivities of neutrophil responses to a selective protein kinase C inhibitor Ro 31-8425; redundancy in signal transduction.

J E Merritt1, J A Sullivan, J Tse, S e Wilkinson, J S Nixon.   

Abstract

Previous studies implicating a role for protein kinase C (PKC) in mediating stimulation of cellular responses by physiological agonists have relied on use of non-specific inhibitors or direct stimulation of PKC by phorbol esters. However, much of this evidence is questionable. Here, we have investigated the effects of a potent and selective PKC inhibitor, Ro 31-8425, on three different responses of human neutrophils stimulated by either a physiological agonist, C5a, or a phorbol ester, PMA. The responses studied were superoxide generation, collagenase secretion and adhesion to endothelial cells. In each case, the PMA-stimulated response was more sensitive to inhibition than the C5a-stimulated response. Even the PMA-stimulated responses differed in their sensitivity to inhibition, with superoxide production being the most sensitive and adhesion at least sensitive. The different sensitivities of the PMA stimulated responses suggest that, although activation of PKC stimulates the responses, either different degrees of activation or different isozymes are required for the different responses. The lower sensitivity of the C5a-stimulated responses in each case suggests that PKC activation, if needed at all, is not rate limiting in these signal transduction pathways. These results emphasize the redundancy in intracellular signal transduction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067630     DOI: 10.1016/s0898-6568(96)00097-6

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  3 in total

1.  Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor.

Authors:  Rita Selvatici; Francesco Congestrì; Giuliano Marzola; Remo Guerrini; Anna Siniscalchi; Susanna Spisani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-07-20       Impact factor: 3.000

2.  Regulation of human neutrophil-mediated cartilage proteoglycan degradation by phosphatidylinositol-3-kinase.

Authors:  C S Hii; L A Marin; D Halliday; D M Roberton; A W Murray; A Ferrante
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

3.  A cell-based drug delivery platform for treating central nervous system inflammation.

Authors:  Oren Levy; Veit Rothhammer; Ivan Mascanfroni; Zhixiang Tong; Rui Kuai; Michael De Biasio; Qingping Wang; Tahir Majid; Christelle Perrault; Ada Yeste; Jessica E Kenison; Helia Safaee; Juliet Musabeyezu; Martina Heinelt; Yuka Milton; Heidi Kuang; Haoyue Lan; William Siders; Marie-Christine Multon; Jonathan Rothblatt; Salam Massadeh; Manal Alaamery; Ali H Alhasan; Francisco J Quintana; Jeffrey M Karp
Journal:  J Mol Med (Berl)       Date:  2021-01-04       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.